BLUMVIVO Trademark

Trademark Overview

On Friday, July 1, 2022, a trademark application was filed for BLUMVIVO with the United States Patent and Trademark Office. The USPTO has given the BLUMVIVO trademark a serial number of 97485018. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, November 21, 2023. This trademark is owned by Sage Therapeutics, Inc.. The BLUMVIVO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression
blumvivo

General Information

Serial Number97485018
Word MarkBLUMVIVO
Filing DateFriday, July 1, 2022
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, November 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSage Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, November 27, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Monday, November 27, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, November 21, 2023ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, November 21, 2023EXPARTE APPEAL TERMINATED
Monday, November 20, 2023EXPARTE APPEAL DISMISSED
Monday, November 20, 2023EXPARTE APPEAL DISMISSED
Monday, November 20, 2023EXPARTE APPEAL DISMISSED
Monday, November 20, 2023EXPARTE APPEAL DISMISSED
Monday, November 20, 2023EXPARTE APPEAL DISMISSED
Monday, November 20, 2023EXPARTE APPEAL DISMISSED
Thursday, September 28, 2023EX PARTE APPEAL-INSTITUTED
Thursday, September 28, 2023EXPARTE APPEAL RECEIVED AT TTAB
Thursday, June 29, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, June 29, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, March 29, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, March 29, 2023FINAL REFUSAL E-MAILED
Wednesday, March 29, 2023FINAL REFUSAL WRITTEN
Wednesday, March 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 3, 2023ASSIGNED TO EXAMINER
Thursday, July 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 5, 2022NEW APPLICATION ENTERED

Related Keywords

blumvivo depression disorders anxiety disorder bipolar diseases system preparations treatment central